David Zaccardelli | Chief Executive Officer |
Mark Hahn | Chief Financial Officer |
Kathy Rickard | Chief Medical Officer |
Julian Harrison | BTIG |
Liana Moussatos | Wedbush |
Iris Long | Berenberg Capital Markets |
Adam Walsh | Stifel |
Peter Welford | Jefferies |
Welcome to Verona Pharma Full Year 2019 Financial Results and Operating Highlights Conference Call. All lines have been placed on mute to prevent any background noise.
Following the speakers’ remarks, there will a question-and-answer session.
Before we begin, I would like to remind you that during today's call statements about the company's future expectations, plans and prospects constitutes forward-looking statements. These forward-looking statements are based on management's current expectations.